Estrella Immunopharma, Inc. (ESLA)

Estrella Immunopharma Statistics

Total Valuation

ESLA has a market cap or net worth of $31.86 million. The enterprise value is $31.45 million.

Market Cap	31.86M
Enterprise Value	31.45M

Important Dates

The next estimated earnings date is Wednesday, August 20, 2025, after market close.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	n/a

Share Statistics

ESLA has 36.17 million shares outstanding. The number of shares has increased by 92.21% in one year.

Current Share Class	36.17M
Shares Outstanding	36.17M
Shares Change (YoY)	+92.21%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	2.70%
Owned by Institutions (%)	1.70%
Float	9.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	234.55
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.22

Current Ratio	0.22
Quick Ratio	0.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	572.86%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ESLA has paid $139 in taxes.

Income Tax	139
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.24% in the last 52 weeks. The beta is 0.37, so ESLA's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	-4.24%
50-Day Moving Average	0.99
200-Day Moving Average	1.02
Relative Strength Index (RSI)	42.47
Average Volume (20 Days)	521,966

Short Selling Information

The latest short interest is 253,236, so 0.70% of the outstanding shares have been sold short.

Short Interest	253,236
Short Previous Month	11,541
Short % of Shares Out	0.70%
Short % of Float	2.55%
Short Ratio (days to cover)	0.56

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.49M
Pretax Income	-6.09M
Net Income	-10.49M
EBITDA	n/a
EBIT	-10.49M
Earnings Per Share (EPS)	-$0.29

Balance Sheet

The company has $421,473 in cash and $10,000 in debt, giving a net cash position of $411,473 or $0.01 per share.

Cash & Cash Equivalents	421,473
Total Debt	10,000
Net Cash	411,473
Net Cash Per Share	$0.01
Equity (Book Value)	-1.83M
Book Value Per Share	-0.05
Working Capital	-3.33M

Cash Flow

Operating Cash Flow	-2.46M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ESLA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-92.21%
Shareholder Yield	-92.21%
Earnings Yield	-32.92%
FCF Yield	n/a

Analyst Forecast

The average price target for ESLA is $16.00, which is 1,716.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	1,716.12%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	12.35%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1